Pacific Channel Aids British Company Indigix
Pacific Channel has provided business planning and product development support to a British company, Indigix, which raised seed capital of £930,000 (NZ$1.926 million).
The seed investment was led by London-based Imperial Innovations Group plc (AIM: IVO), a leading technology commercialisation and investment company, alongside Kurma BioFund, a Paris-based life sciences fund.
Pacific Channel has provided general management, project planning, budgeting and investment statement preparation services to Indigix and continues to advise the company following the seed funding round.
Indigix is developing a novel platform technology that enables it to engineer synthetic molecules for modifying defined immunological responses in a variety of major medical diseases. Potential applications for Indigix’s technology include the treatment of diarrhoeal diseases, inflammatory bowel disease and improved wound healing.
Dr Robert Feldman, Executive Director of Pacific
Channel Ltd. said,
“It has been a real pleasure to
have been involved with the founding and development of
Indigix and it is most gratifying to see the successful seed
investment and to have been part of the team that has
generated the success.”
About Pacific
Channel
Pacific Channel Limited is a venture
creation, support, development and investment firm focused
on life science and engineering technologies. Pacific
Channel is a private, limited liability company formed in
2005. Through our expertise and access to financial capital,
Pacific Channel facilitates the growth of commercially
viable early-stage life sciences and clean-tech companies.
Pacific Channel aims to both found high growth potential companies and support a selected number of clients with its experience, knowledge and collegial network of proven experts to reduce business risk to the underlying technology risk for innovative products.
Both Pacific Channel’s own seed investments and its aligned seed facilitation are focused, exclusively on life sciences and engineering investments primarily with a New Zealand nexus. Pacific Channel focuses on life sciences and engineering innovations that have the potential to create both significant wealth and socially valuable results.
ENDS